NASDAQ: STRO SUTRO BIOPHARMA, INC. 8-K

Sutro Biopharma reports Q1 2026 financial results

Filed May 14, 2026 · Period ending May 14, 2026 · ~1 min read

Key Changes

  • medium

    Sutro Biopharma announced Q1 2026 financial results for the quarter ended March 31, 2026 via press release. The 8-K references the attached press release but does not include specific financial metrics in the filing body.

See the full narrative summary and section-by-section diff — create a free account to read more. Takes 30 seconds.

Partner

Trade STRO commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 9, 2026 4:41 PM